Sorafenib with ASC-J9<sup>®</sup>synergistically suppresses the HCC progression<i>via</i>altering the pSTAT3-CCL2/Bcl2 signals

Junjie Xu(Kunming University of Science and Technology), Chawnshang Chang(China Medical University), Hui Lin(Ningbo University), Yin Sun(University of Rochester Medicine), Wen‐Lung Ma(Asia University), Liang Shi(National Instruments (Ireland)), Xiujun Cai(National Instruments (Ireland)), Jiang Chen(Sir Run Run Shaw Hospital), Gonghui Li(Sir Run Run Shaw Hospital)
International Journal of Cancer
September 26, 2016
10.1002/ijc.30446
Cited by 37

Related Papers

Induction of the TRPM-2 gene in cells undergoing programmed death.
|Molecular and Cellular Biology|1989|463
Acetylation of Androgen Receptor Enhances Coactivator Binding and Promotes Prostate Cancer Cell Growth
|Molecular and Cellular Biology|2003|271
Interaction of the Ski Oncoprotein with Smad3 Regulates TGF-β Signaling
|Molecular Cell|1999|262
Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
|Gastroenterology|2008|253
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
|Nature Communications|2019|223